Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome.

Dyar, Brianna; Meaddough, Erika; Sarasua, Sara M; Rogers, Curtis; Phelan, Katy; Boccuto, Luigi

Dyar, Brianna; Meaddough, Erika; Sarasua, Sara M; Rogers, Curtis; Phelan, Katy; Boccuto, Luigi.

Afiliação

Dyar B; Healthcare Genetics Program, School of Nursing, Clemson University, Clemson, SC 29634, USA.
Meaddough E; Healthcare Genetics Program, School of Nursing, Clemson University, Clemson, SC 29634, USA.
Sarasua SM; Healthcare Genetics Program, School of Nursing, Clemson University, Clemson, SC 29634, USA.
Rogers C; Greenwood Genetic Center, Greenwood, SC 29649, USA.
Phelan K; Florida Cancer Specialists & Research Institute, Fort Myers, FL 33905, USA.
Boccuto L; Healthcare Genetics Program, School of Nursing, Clemson University, Clemson, SC 29634, USA.

Genes (Basel) ; 12(8)2021 07 30.

Article em En | MEDLINE | ID: mdl-34440366

Assuntos

Transtornos Cromossômicos/tratamento farmacológico; Transtornos Cromossômicos/genética; Medicina de Precisão; Deleção Cromossômica; Cromossomos Humanos Par 22/genética; Citocromo P-450 CYP2D6/genética; Desenvolvimento de Medicamentos; Humanos; Testes Farmacogenômicos

Palavras-chave

CYP2D6; Phelan-McDermid syndrome; SHANK3; autism; therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Cromossômicos / Medicina de Precisão Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google